id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-C-0971-0009,FDA,FDA-2024-C-0971,Listing of Color Additives Exempt From Certification; Butterfly Pea Flower Extract; Confirmation of Effective Date,Rule,Confirmation of Effective Date,2025-08-21T04:00:00Z,2025,8,,,2025-08-21T17:22:33Z,2025-16045,0,0,09000064b8f0b33c
FDA-2024-C-0971-0001,FDA,FDA-2024-C-0971,Listing of Color Additives Exempt From Certification; Butterfly Pea Flower Extract,Rule,Final Rule,2025-05-12T04:00:00Z,2025,5,2025-05-12T04:00:00Z,2025-06-12T03:59:59Z,2025-06-03T09:00:19Z,2025-08248,0,0,09000064b8d3d224
FDA-2024-C-0971-0004,FDA,FDA-2024-C-0971,"Reference 1 - Memorandum from B. Petigara-Harp, Color Technology Branch, Division of Color Certification and Technology, Office of
Cosmetics and Colors (OCAC), Office of Commissioner, Office of Chief Scientist, FDA to S. DiFranco, Regulatory Management Branch (RMB), Division of Food Ingredients (DFI), Office of Premarket Additive Safety (OPMAS), HFP, FDA, April 21, 2025.",Supporting & Related Material,Background Material,2025-05-12T04:00:00Z,2025,5,,,2025-05-21T22:23:27Z,,0,0,09000064b8d0906d
FDA-2024-C-0971-0007,FDA,FDA-2024-C-0971,"Reference 4 - Memorandum from Y. Zang, Toxicology Review Team, DFI, Office of Food Additive Safety (OFAS), Center for Food and Human Nutrition (CFSAN), FDA, to S. DiFranco, DFI, OFAS, CFSAN, FDA, June 9, 2021.",Supporting & Related Material,Background Material,2025-05-12T04:00:00Z,2025,5,,,2025-05-21T22:23:27Z,,0,0,09000064b8d115a4
FDA-2024-C-0971-0002,FDA,FDA-2024-C-0971,Memorandum - CAP 4C0328 – Amending the color additive regulations to provide for the use of Butterfly Pea Flower (BPF) extract as a color additive in a variety of foods,Other,Memorandum,2025-05-12T04:00:00Z,2025,5,2025-05-12T04:00:00Z,,2025-05-21T22:28:32Z,,0,0,09000064b8d0d876
FDA-2024-C-0971-0003,FDA,FDA-2024-C-0971,89 FR 8537,Supporting & Related Material,Background Material,2025-05-12T04:00:00Z,2025,5,,,2025-05-21T22:27:46Z,,0,0,09000064b8d125c7
FDA-2024-C-0971-0006,FDA,FDA-2024-C-0971,"Reference 3 - Memorandum from T. Thurmond, Toxicology Review Branch (TRB), DFI, OPMAS, HFP, FDA to S. DiFranco, RMB, DFI, OPMAS, HFP, FDA, April 21, 2025",Supporting & Related Material,Background Material,2025-05-12T04:00:00Z,2025,5,,,2025-05-21T22:23:27Z,,0,0,09000064b8d0906f
FDA-2024-C-0971-0005,FDA,FDA-2024-C-0971,"Reference 2 - Memorandum from H. Thapa, Chemistry Evaluation Branch, DFI, OPMAS, HFP, FDA to S. DiFranco, RMB, DFI, OPMAS, HFP, FDA, April 21, 2025.",Supporting & Related Material,Background Material,2025-05-12T04:00:00Z,2025,5,,,2025-05-21T22:23:27Z,,0,0,09000064b8d0906e